What is Candel Therapeutics Inc (CADL) stock price today?

Candel Therapeutics Inc (CADL) currently trades at $6.18 per share. The stock has a market capitalization of $476.11M and a P/E ratio of —x.

Is CADL stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Candel Therapeutics Inc has a Smart Value Score of 20/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Candel Therapeutics Inc's revenue and earnings?

Candel Therapeutics Inc has trailing twelve-month (TTM) revenue of $31000.00 with profit margins of 0.00%. Earnings per share (EPS) is $-0.72.

CADL

Candel Therapeutics Inc

NASDAQ: CADL · HEALTHCARE · BIOTECHNOLOGY

$6.18

-0.32% today

Updated 2026-04-29

Market cap

$476.11M

P/E ratio

—

P/S ratio

436.42x

EPS (TTM)

$-0.72

Dividend yield

—

52W range

$4 – $8

Volume

1.6M

Market cap

$476.11M

P/E ratio

—

P/S ratio

436.42x

EPS (TTM)

$-0.72

Dividend yield

—

52W range

$4 – $8

Volume

1.6M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target

$18.88

+205.50%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy7 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-10.98M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$125000.00	$31000.00	$0.00	$0.00	$31000.00
Net income	$-18.79M	$-37.94M	$-55.18M	$-38.18M	$-29.50M
EPS	—	—	—	—	$-0.72
Free cash flow	$-32.72M	$-34.70M	$-27.04M	$-38.90M	$-10.98M
Profit margin	-15,035.20%	-122,383.87%	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-03-31	PAPA, JOSEPH C	Buy	2,795	$4.11
2026-03-31	MANNING, PAUL B	Buy	4,618	$4.11
2026-03-31	LOGGIA, NICOLETTA	Buy	779	$4.11

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CADL	$476.11M	20	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Candel Therapeutics Inc trades at $6.18. Our Smart Value Score of 20/100 indicates the stock is weak. TTM revenue stands at $31000.00.

Frequently asked questions

What is Candel Therapeutics Inc's stock price?

Candel Therapeutics Inc (CADL) trades at $6.18.

Is Candel Therapeutics Inc overvalued?

Smart Value Score 20/100 (Grade F, Strong Sell).

What is the price target of Candel Therapeutics Inc (CADL)?

The analyst target price is $18.88, representing +205.5% upside from the current price of $6.18.

What is Candel Therapeutics Inc's revenue?

TTM revenue is $31000.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio436.42x

ROE-64.60%

Beta-0.81

50D MA$5.29

200D MA$5.56

Shares out0.07B

Float0.06B

Short ratio—

Avg volume1.6M

Performance

1 week-14.31%

1 month+40.40%

3 months+9.58%

YTD+11.33%

1 year—

3 years—

5 years—

Compare

CADL vs LLY →CADL vs JNJ →CADL vs ABBV →Stock screener →